Muscle Pharm Corporation (MSLPQ)

[Aspenots]

Great, how's this for transparency? From the 424B4, top of page 14.

Other than the bridge loan and debt payments, we have not allocated specific amounts of the net proceeds from this offering for any of the foregoing purposes. Accordingly, our management will have significant discretion and flexibility in applying these proceeds. You will be relying on the judgment of our management with regard to the use of these net proceeds, and you will not have the opportunity, as part of your investment decision, to assess whether the net proceeds are being used appropriately. It is possible that the net proceeds will be invested in a way that does not yield a favorable, or any, return for us. The failure of our management to use such funds effectively could have a material adverse effect on our business, financial condition, operating results and cash flow.

But I guess it's a good sign they've finally set a price and put numbers in the offering sections where it was blank previously. This is offering is probably the reason the price has been bolstered above $4.00. I wouldn't be surprised if they kept it above $4.20 until the series D shares are sold.